← Back to all trials
Active Not Recruiting
NCT05625945
Physical Activity Levels and Statin Therapy
Conditions: Cardiovascular Diseases, HMG COA Reductase Inhibitor Adverse Reaction, Muscle Pain
Sex: All
Ages: 18 Years – N/A
Enrollment: 200
Sponsor: Radboud University Medical Center
Location: Netherlands
Summary
Rationale: Combining statin treatment and physical activity is very effective for the prevention of cardiovascular diseases.
Statins are well-tolerated by most patients, but may cause statin-associated muscle symptoms (SAMS).Objective: To identify predictors for SAMS in statin users and to objectively assess physical activity levels and sedentary time between symptomatic and asymptomatic statin users.
Eligibility Criteria
Inclusion Criteria:Mentally able to give informed consentStatin treatment for at least 3 monthsExclusion Criteria:Known hereditary muscle defectKnown mitochondrial diseaseOther diseases known to cause muscle symptoms (e.g. m.
Parkinson or rheumatic diseases)
Source: ClinicalTrials.gov (NCT05625945). StuddyBuddy aggregates publicly available trial information.
